A section of Antibiotics (ISSN 2079-6382).
One of the major challenges of the 21st century in biological sciences is the discovery of new molecules with antimicrobial properties and active on bacterial strains that are multi-resistant to the antibiotics currently available in our therapeutic arsenal. Peptides are a family of molecules that are capable of acting effectively against such bacteria—in particular those responsible for nosocomial diseases such as the methicillin-resistant Staphylococcus aureus (MRSA) and extended-spectrum beta-lactamase-producing Enterobacteriaceae. Interestingly, antibacterial peptides are part of the arsenal of host defense peptides that are present in a variety of simple and complex life forms, from prokaryotes (e.g., bacteriocins) to eucaryotes (e.g., defensins, cathelicidins). Due to their particular antibacterial potential, they are currently emerging as solid candidate therapeutic compounds against both pathogenic Gram-positive and Gram-negative bacteria, including those resistant to ‘conventional’ antibiotics. Many applications of antimicrobial peptides do exist in various fields, including human and animal health, feeding, agriculture and cosmetic/dermatologic fields.
The Section ‘Antimicrobial Peptides’ of the journal Antibiotics focuses on the various aspects of antibacterial/antimicrobial peptides from natural (e.g., animal venoms, milk) or non-natural sources (synthetic de novo designed peptides), from their discovery to the structural and functional characterization, the mode of action at a molecular level, as well as the development and evaluation in clinical trials. Potential contributors are strongly encouraged to submit their best work(s) in this important emerging field of applied scientific research.
Following special issues within this section are currently open for submissions:
- Design, Modification and Application of Antimicrobial Peptides (Deadline: 30 September 2023)
- The Century-Long Journey of Peptide-Based Drugs (Deadline: 30 September 2023)
- Insights on Antimicrobial Peptides and Peptidomimetics, and Their Antimicrobial Potential (Deadline: 30 November 2023)
- Antimicrobial Peptides: A New Hope in the War against Multi-Drug Resistance (Deadline: 30 November 2023)
- The Role of Antimicrobial Peptides in Tackling Antimicrobial Resistance (Deadline: 30 November 2023)
- Antimicrobial Peptides (AMPs): Structure, Target, Spatiotemporal Relationship, and Druggability (Deadline: 15 December 2023)
- Membranes to Fight Drug-Resistant Microbes (Deadline: 31 December 2023)
- Bioactive Peptides and Their Antibiotic Activity (Deadline: 31 December 2023)
- Discovery and Multifunctionality of Anti-microbial Peptides (Deadline: 31 December 2023)
- Mechanisms of Antimicrobial Peptides on Pathogens, 2nd Edition (Deadline: 31 January 2024)
- Potential of Antimicrobial Peptides for an Exciting Future (Deadline: 31 January 2024)
- Reviews on Antimicrobial Peptides (Deadline: 15 February 2024)
- Lipopeptide Surfactants as Potential Antimicrobial Agents (Deadline: 29 February 2024)
- Insights into Natural Antimicrobial Peptides (Deadline: 31 March 2024)